Literature DB >> 15230336

Pharmacokinetics of TJ-8117 (Onpi-to), a drug for renal failure (I): Plasma concentration, distribution and excretion of [3H]-(-)epicatechin 3-O-gallate in rats and dogs.

Yukiho Takizawa1, Hiroaki Nishimura, Takashi Morota, Hiroki Tomisawa, Shuichi Takeda, Masaki Aburada.   

Abstract

TJ-8117 (Onpi-to) is an herbal medicine extracted from a mixture of five crude medicinals (Rhei Rhizoma, Glycyrrhizae Radix, Ginseng Radix, Zingiberis Rhizoma and Aconiti Tuber), which has been developed as a drug for chronic renal failure. (-)Epicatechin 3-O-gallate (ECG), one of the active components of TJ-8117, was labeled with tritium and added to TJ-8117. Pharmacokinetics in plasma, tissue distribution and excretion of radioactivity were investigated following a single oral administration of TJ-8117 containing [3H]ECG ([3H]TJ-8117) in rats and dogs. 1. Following oral administration of [3H]TJ-8117, radioactivity exhibited linear pharmacokinetics in Cmax. Linearity of AUC(0-72 h) was lost at the highest dose of [3H]TJ-8117. Cmax and AUC(0-72 h) were higher in female rats than in male rats, a finding which suggested a sex difference in rats. Plasma levels of radioactivity displayed curves with one peak in dogs, which suggested a species difference between rats and dogs. 2. No accumulation was observed in any tissues in male rats. 3. Within 168 h after administration of [3H]TJ-8117 to male rats, 18.7%, 84.1% and 0.9% of the dose was excreted in urine, feces and expired air, respectively. Data from bile-duct cannulated rats indicated that at least 18.4% of the dose was absorbed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15230336     DOI: 10.1007/BF03190582

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  Absorption, distribution, elimination of tea polyphenols in rats.

Authors:  L Chen; M J Lee; H Li; C S Yang
Journal:  Drug Metab Dispos       Date:  1997-09       Impact factor: 3.922

2.  Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria.

Authors:  M R Meselhy; N Nakamura; M Hattori
Journal:  Chem Pharm Bull (Tokyo)       Date:  1997-05       Impact factor: 1.645

3.  Effects of rhubarb tannins on renal function in rats with renal failure.

Authors:  T Yokozawa; K Fujioka; H Oura; G Nonaka; I Nishioka
Journal:  Nihon Jinzo Gakkai Shi       Date:  1993-01

4.  [Effects of onpi-to (TJ-8117) and (-)epicatechin-3-O-gallate on the proliferating changes in glomeruli of 5/6 nephrectomized rats].

Authors:  N Fujitsuka; A Kurogi; T Hattori; S Shindo
Journal:  Nihon Jinzo Gakkai Shi       Date:  1997-10

5.  Pharmacokinetics of (-)-epicatechin-3-O-gallate, an active component of Onpi-to, in rats.

Authors:  Yukiho Takizawa; Takashi Morota; Shuichi Takeda; Masaki Aburada
Journal:  Biol Pharm Bull       Date:  2003-05       Impact factor: 2.233

6.  Absorption of tea catechins into rat portal vein.

Authors:  K Okushio; N Matsumoto; T Kohri; M Suzuki; F Nanjo; Y Hara
Journal:  Biol Pharm Bull       Date:  1996-02       Impact factor: 2.233

7.  Effects of rhubarb tannins on uremic toxins.

Authors:  T Yokozawa; K Fujioka; H Oura; G Nonaka; I Nishioka
Journal:  Nephron       Date:  1991       Impact factor: 2.847

  7 in total
  3 in total

1.  Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs.

Authors:  S-H Lee; J-L Ghim; M-H Song; H-G Choi; B-M Choi; H-M Lee; E-K Lee; Y-J Roh; G-J Noh
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

2.  Pharmacokinetics of TJ-8117(Onpi-to), a drug for renal failure (II): effects of food, repeated administration and renal failure to plasma concentration of [3H]-(-)epicatechin 3-O-gallate in rats.

Authors:  Yukiho Takizawa; Toshimi Morita; Naoki Fujitsuka; Akiko Kido; Shouichirou Shindou; Hiroki Tomisawa; Yoshio Kase; Shuichi Takeda; Masaki Aburada; Keńtchi Miyamoto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

3.  Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein.

Authors:  Chang Ho Lee; Soo-Han Lee; Ji Hyun Kim; Yook-Hwan Noh; Gyu-Jeong Noh; Seong-Wook Lee
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-06       Impact factor: 10.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.